Nexgel (NXGLW) Change in Accured Expenses (2018 - 2025)
Nexgel (NXGLW) reported Change in Accured Expenses of -$70000.0 for Q4 2025, up 76.82% on a YoY basis from -$39588.0 in Q4 2024, and down 1650.0% quarter-over-quarter from -$4000.0 in Q3 2025.
Nexgel (NXGLW) Change in Accured Expenses (2018 - 2025) Analysis & Trends
Nexgel has reported Change in Accured Expenses for 8 years, with the latest figure at -$70000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 76.82% year-over-year to -$70000.0; the trailing twelve-month figure through Dec 2025 stood at $150000.0 (up 134.56% YoY), and the FY2025 full-year result was $150000.0, up 134.56% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at -$70000.0, down from -$4000.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $200000.0 in Q2 2025, with the low at -$302000.0 in Q4 2024.
- Historically, Change in Accured Expenses has averaged -$10300.0 across 5 years, with a median of -$3000.0 in 2022.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 1450.0% — and 2024, when it sank 1494.44%.
- Nexgel's Change in Accured Expenses stood at $3000.0 in 2021, then slumped by 1266.67% to -$35000.0 in 2022, then jumped by 354.29% to $89000.0 in 2023, then tumbled by 439.33% to -$302000.0 in 2024, then jumped by 76.82% to -$70000.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$70000.0 (Q4 2025), -$4000.0 (Q3 2025), and $200000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -284.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -32.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.88 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -151.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 5.38 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Nexgel | - | - | 819,000.00 | -70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -70,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | -302,000.00 |
| Dec 31, 2024 | -302,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Jun 30, 2024 | 174,000.00 |
| Jun 30, 2024 | 174,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | -139,000.00 |
| Sep 30, 2023 | -139,000.00 |